医中誌リンクサービス


文献リスト

1)Wu LM, Xu JR, Gu HY, et al. Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease? Dig Dis Sci. 2013; 58: 3313-25
PubMed CrossRef
医中誌リンクサービス
2)Liu X, Zou L, Liu F, et al. Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. PLoS One. 2013; 8: e70896
CrossRef
医中誌リンクサービス
3)Junqiang L, Yinzhong W, Li Z, et al. Gadoxetic acid disodium (Gd-EOBDTPA)-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. J Magn Reson Imaging. 2014; 39: 1079-87
PubMed CrossRef
医中誌リンクサービス
4)Chen L, Zhang J, Zhang L, et al. Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One. 2012; 7: e48681
CrossRef
医中誌リンクサービス
5)Higaki A, Tamada T, Sone T, et al. Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging. Magn Reson Imaging. 2012; 30: 689-93
PubMed CrossRef
医中誌リンクサービス
6)Kumada T, Toyoda H, Tada T, et al. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol. 2011; 197: 58-63
PubMed CrossRef
医中誌リンクサービス
7)Motosugi U, Ichikawa T, Sano K, et al. Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease. J Magn Reson Imaging. 2011; 34: 88-94
PubMed CrossRef
医中誌リンクサービス
8)Kim YK, Lee WJ, Park MJ, et al. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology. 2012; 265: 104-14
PubMed CrossRef
医中誌リンクサービス
9)Takechi M, Tsuda T, Yoshioka S, et al. Risk of hypervascularization in small hypovascular hepatic nodules showing hypointense in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease. Jpn J Radiol. 2012; 30: 743-51
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
10)Inoue T, Hyodo T, Murakami T, et al. Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors. Dig Dis. 2013; 31: 472-9
PubMed CrossRef
医中誌リンクサービス
11)Hyodo T, Murakami T, Imai Y, et al. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. Radiology. 2013; 266: 480-90
PubMed CrossRef
医中誌リンクサービス
12)Yamamoto A, Ito K, Tamada T, et al. Newly developed hypervascular hepatocellular carcinoma during follow-up periods in patients with chronic liver disease: observation in serial gadoxetic acid-enhanced MRI. AJR Am J Roentgenol. 2013; 200: 1254-60
PubMed CrossRef
医中誌リンクサービス
13)Ichikawa S, Ichikawa T, Motosugi U, et al. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. J Magn Reson Imaging. 2014; 39: 293-7
PubMed CrossRef
医中誌リンクサービス
14)Narita M, Hatano E, Arizono S, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol. 2009; 44: 793-8
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
15)Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma:signal intensity at gadoxetic acid-enhanced MR Imaging – correlation with molecular transporters and histopathologic features. Radiology. 2010; 256: 817-26
PubMed CrossRef
医中誌リンクサービス
16)Kitao A, Matsui O, Yoneda Y, et al. Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology. 2012; 265: 780-9
PubMed CrossRef
医中誌リンクサービス
17)Yoneda N, Matsui O, Kitao A, et al. Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature. Jpn J Radiol. 2013; 31: 480-90
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
18)Sekine S, Ogawa R, Ojima H, et al. Expression of SLCO1B3 is associated with intratumoral cholestasis and CTNNB1 mutations in hepatocellular carcinoma. Cancer Sci. 2011; 102: 1742-7
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
19)Mao TL, Chu JS, Jeng YM, et al. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. J Pathol. 2001; 193: 95-101
PubMed CrossRef
医中誌リンクサービス
20)Motosugi U, Ichikawa T, Sano K, et al. Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol. 2010; 28: 623-7
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
21)Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007; 245: 458-66
PubMed CrossRef
医中誌リンクサービス
22)Motosugi U, Ichikawa T, Sou H, et al. Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography. Magn Reson Imaging. 2012; 30: 128-32
PubMed CrossRef
医中誌リンクサービス
23)Ichikawa S, Motosugi U, Ichikawa T, et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci. 2012; 11: 291-7
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
24)Shi Y, Guo Q, Xia F, et al. MR Elastography for the Assessment of Hepatic Fibrosis in Patients with Chronic Hepatitis B Infection: Does Histologic Necroinflammation Influence the Measurement of Hepatic Stiffness? Radiology. 2014; 132592
PubMed
医中誌リンクサービス
25)Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology. 2008; 135: 32-40
医中誌リンクサービス
26)Yoon JH, Lee JM, Joo I, et al. Hepatic Fibrosis: Prospective Comparison of MR Elastography and US Shear Wave Elastography for Evaluation. Radiology. 2014 Jul 7.[Epub ahead of print]
PubMed
医中誌リンクサービス
27)Kanematsu M, Goshima S, Watanabe H, et al. Diffusion/perfusion MR imaging of the liver: practice, challenges, and future. Magn Reson Med Sci. 2012; 11: 151-61
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
28)Wang Q-B, Zhu H, Liu H-L, et al. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology. 2012; 56: 239-47
PubMed CrossRef
医中誌リンクサービス
29)Motosugi U, Ichikawa T, Sou H, et al. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging. 2009; 30: 1042-6
PubMed CrossRef
医中誌リンクサービス
30)Watanabe H, Kanematsu M, Goshima S, et al. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging – preliminary observations. Radiology. 2011; 259: 142-50
PubMed CrossRef
医中誌リンクサービス
31)Motosugi U, Ichikawa T, Oguri M, et al. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging. 2011; 29: 1047-52
PubMed CrossRef
医中誌リンクサービス
32)Chen BB, Hsu CY, Yu CW, et al. Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid. Invest Radiol. 2012; 47: 649-55
PubMed CrossRef
医中誌リンクサービス
33)Wang YX, Yuan J, Chu ES, et al. T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model. Radiology. 2011; 259: 712-9
PubMed CrossRef
医中誌リンクサービス
34)Allkemper T, Sagmeister F, Cicinnati V, et al. Evaluation of fibrotic liver disease with whole-liver T1ρ MR imaging: a feasibility study at 1.5 T. Radiology. 2014; 271: 408-15
PubMed CrossRef
医中誌リンクサービス
35)Rauscher I, Eiber M, Ganter C, et al. Evaluation of T1ρ as a potential MR biomarker for liver cirrhosis: comparison of healthy control subjects and patients with liver cirrhosis. Eur J Radiol. 2014; 83: 900-4
PubMed CrossRef
医中誌リンクサービス
36)Bohte AE, van Werven JR, Bipat S, et al. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011; 21: 87-97
PubMed CrossRef
医中誌リンクサービス
37)Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011; 54: 1082-90
PubMed CrossRef
医中誌リンクサービス
38)Masaki K, Takaki S, Hyogo H, et al. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases. Hepatol Res. 2013; 43: 1182-9
医学中央雑誌刊行会  CrossRef
医中誌リンクサービス
39)Jung KS, Kim BK, Kim SU, et al. Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease. PLoS One. 2014; 9: e98689
CrossRef
医中誌リンクサービス
40)Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41: 1313-21
PubMed CrossRef
医中誌リンクサービス
41)de Ledinghen V, Vergniol J, Capdepont M, et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol. 2014; 60: 1026-31
CrossRef
医中誌リンクサービス
42)Park YS, Park SH, Lee SS, et al. Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology. 2011; 258: 760-6
PubMed CrossRef
医中誌リンクサービス
43)Fischer MA, Gnannt R, Raptis D, et al. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest Radiol. 2011; 46: 351-8
PubMed CrossRef
医中誌リンクサービス
44)Hur BY, Lee JM, Hyunsik W, et al. Quantification of the Fat Fraction in the Liver Using Dual-Energy Computed Tomography and Multimaterial Decomposition. J Comput Assist Tomogr. 2014 Aug 26. [Epub ahead of print]
PubMed
医中誌リンクサービス
45)Mendonca P, Lamb P, Sahani D. A Flexible Method for Multi-Material Decomposition of Dual-Energy CT Images. IEEE Trans Med Imaging. 2013 Sep 16. [Epub ahead of print]
医中誌リンクサービス
46)Ligabue G, Besutti G, Scaglioni R, et al. MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends. Quant Imaging Med Surg. 2013; 3: 192-5
医中誌リンクサービス
47)Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011; 34: 729-49
PubMed CrossRef
医中誌リンクサービス
48)Hines CD, Agni R, Roen C, et al. Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse. J Magn Reson Imaging. 2012; 35: 844-51
PubMed CrossRef
医中誌リンクサービス
49)Kuhn JP, Hernando D, Mensel B, et al. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging. 2014; 39: 1494-501
PubMed CrossRef
医中誌リンクサービス
50)Kuhn JP, Hernando D, Munoz del Rio A, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology. 2012; 265: 133-42
PubMed CrossRef
医中誌リンクサービス
51)Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology. 2011; 258: 767-75
PubMed CrossRef
医中誌リンクサービス
52)Deng J, Fishbein MH, Rigsby CK, et al. Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease. Pediatr Radiol. 2014 May 20. [Epub ahead of print]
PubMed
医中誌リンクサービス
53)Hines CD, Frydrychowicz A, Hamilton G, et al. T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging. 2011; 33: 873-81
PubMed CrossRef
医中誌リンクサービス
54)Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013; 267: 422-31
PubMed CrossRef
医中誌リンクサービス
55)Awai HI, Newton KP, Sirlin CB, et al. Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol. 2014; 12: 765-73
CrossRef
医中誌リンクサービス
56)Permutt Z, Le TA, Peterson MR, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther. 2012; 36: 22-9
PubMed CrossRef
医中誌リンクサービス


NPO医学中央雑誌刊行会
https://www.jamas.or.jp/
info@jamas.or.jp